Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 5, 2010Nutrition and Cancer

Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

RERon EpelbaumUniversity of BernMSMoshe SchafferBen-Gurion University of the NegevBVB. VizelRambam Health Care Campus

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Epelbaum et al. (2010) studied this question.

synapsesocial.com/papers/6a82f53cf2457b8164efdb5ehttps://doi.org/10.1080/01635581.2010.513802
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.1997 · 5,940 citations
  2. 2Strategy and planning for chemopreventive drug development: Clinical development plans II1996 · 196 citations
  3. 3New Guidelines to Evaluate the Response to Treatment in Solid Tumors2000 · 15,764 citations